Travere Therapeutics, Inc.
TVTX
$29.73
$1.485.24%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 254.53M | 319.54M | 322.24M | 370.70M | 277.44M |
| Total Receivables | 84.48M | 40.22M | 36.48M | 29.42M | 27.67M |
| Inventory | 5.55M | 4.09M | 3.93M | 6.20M | 6.36M |
| Prepaid Expenses | 26.55M | 15.72M | 11.52M | 10.39M | 13.28M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 371.11M | 379.57M | 374.17M | 416.70M | 324.74M |
|
|
|||||
| Total Current Assets | 371.11M | 379.57M | 374.17M | 416.70M | 324.74M |
| Net Property, Plant & Equipment | 15.78M | 16.90M | 18.05M | 19.63M | 21.82M |
| Long-term Investments | 753.00K | 753.00K | 753.00K | 753.00K | 747.00K |
| Goodwill | 753.00K | 753.00K | 753.00K | 753.00K | 747.00K |
| Total Other Intangibles | 108.68M | 104.85M | 103.06M | 103.22M | 103.46M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 42.25M | 53.24M | 52.76M | 53.82M | 53.64M |
| Total Assets | 538.58M | 555.31M | 548.80M | 594.13M | 504.41M |
|
|
|||||
| Total Accounts Payable | 18.23M | 19.13M | 15.37M | 23.53M | 23.20M |
| Total Accrued Expenses | 105.76M | 81.68M | 77.11M | 86.03M | 83.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.73M | 74.43M | 74.22M | 74.08M | 73.90M |
| Total Finance Division Other Current Liabilities | 5.35M | 14.29M | 15.76M | 17.11M | 9.39M |
| Total Other Current Liabilities | 5.35M | 14.29M | 15.76M | 17.11M | 9.39M |
| Total Current Liabilities | 135.07M | 189.54M | 182.46M | 200.75M | 190.04M |
|
|
|||||
| Total Current Liabilities | 135.07M | 189.54M | 182.46M | 200.75M | 190.04M |
| Long-Term Debt | 311.37M | 311.02M | 310.66M | 310.31M | 309.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.65M | 14.12M | 15.58M | 17.19M | 18.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.93M | 7.88M | 7.27M | 6.80M | 16.29M |
| Total Liabilities | 465.02M | 522.56M | 515.98M | 535.05M | 534.86M |
|
|
|||||
| Common Stock & APIC | 1.55B | 1.53B | 1.52B | 1.51B | 1.36B |
| Retained Earnings | -1.48B | -1.50B | -1.49B | -1.45B | -1.39B |
| Treasury Stock & Other | -1.05M | -812.00K | -843.00K | -80.00K | -1.02M |
| Total Common Equity | 73.56M | 32.75M | 32.82M | 59.08M | -30.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 73.56M | 32.75M | 32.82M | 59.08M | -30.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 73.56M | 32.75M | 32.82M | 59.08M | -30.45M |
|
|
|||||